Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fennec Pharmaceuticals (FENC) Non-cash Items (2018 - 2024)

Fennec Pharmaceuticals (FENC) has disclosed Non-cash Items for 3 consecutive years, with $5.0 million as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Non-cash Items changed N/A year-over-year to $5.0 million, compared with a TTM value of $5.0 million through Dec 2024, changed N/A, and an annual FY2024 reading of $5.0 million, changed N/A over the prior year.
  • Non-cash Items was $5.0 million for Q4 2024 at Fennec Pharmaceuticals, down from $19.4 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $5.0 million in Q4 2024 and bottomed at $5.0 million in Q4 2024.